Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Peptide libraries

a technology of peptides and libraries, applied in the field of peptides, can solve the problems of not recognising structure as well as structural diversity, and achieve the effects of increasing diversity, promoting even greater diversity, and reducing the number of structural isomers of peptide ligands

Inactive Publication Date: 2017-03-09
BICYCLERD LTD
View PDF1 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention allows for the modification of structured polypeptides by adding or removing groups from their ends. This can affect the function of the polypeptide, such as its binding affinity. The attachment of a molecular scaffold can occur before or after the polypeptide is combined with the scaffold. The use of protective groups like Fmoc or palmitoyl can help to control the conformation of the polypeptide and improve its function. This invention provides a way to modify the structure of polypeptides and their interactions with molecular scaffolds, which can be useful in drug development and other fields.

Problems solved by technology

Although the prior art exploits scaffolds to impart structure to polypeptides, and therefore allows the introduction of conformational diversity through alteration of the sequence of the peptides, it does not recognise that structure as well as structural diversity can be altered by manipulating the interaction between the peptide and the scaffold, as well as changing the scaffold itself.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptide libraries
  • Peptide libraries
  • Peptide libraries

Examples

Experimental program
Comparison scheme
Effect test

example 1

Protease Resistant Bicyclic Peptide Against MDM2

[0251]MDM2 is an enzyme (an E3 ubiquitin ligase) that recognises the trans-activation domain of p53, the tumour suppressor, leading to ubiquitinylation and degradation of p53 by the proteasome. A nutlin inhibitor of the p53-MDM2 interaction can lead to in vivo activation of the p53 pathway, and it has been suggested that such agents may have potential as anti-cancer agents. Here we describe the selection of two bicyclic peptides (PEP10 and PEP48) against MDM2, a target “antigen”. The affinity of each synthetic peptide was in the range 250-750 nM.

[0252]Protocols generally followed those described earlier in Heinis et al., 2009, Nature Chemical Biology 5, 502-507, unless otherwise indicated. In the work of Heinis et al., both targets, kallikrein and cathepsin G, were proteases, and the kallikrein inhibitor is fairly resistant to proteolysis by kallikrein, although it includes a kallikrein cleavage site. MDM2 is not a protease, and theref...

example 2

Oxidation of PK15-TBMB Conjugate to its Sulfoxide and Sulfone

[0305]PK15-TBMB was synthesised as described in Heinis et al., 2009, Nature Chemical Biology 5, 502-507. Approximately 1 mg of PK15-TBMB was dissolved in 1 ml of 1×PBS and hydrogen peroxide added to a concentration of 0.3%. Reaction left at room temperature overnight. MALDI mass spec showed a range of peaks corresponding to the addition of 1,2 and 3 oxygen atoms, but incomplete reaction. Reaction adjusted to 1% H2O2 and left for 8 hrs where it could be seen that the +3 (oxygen) product was major but the reaction still incomplete. The reaction was heated in a microwave synthesiser, initially cooled on ice, up to a temperature of 37° C., with a power of up to 50 W. After 15 mins mass spec showed essentially a single peak at 1992 corresponding to addition of 3 oxygen atoms, and therefore corresponding to the sulphoxides. There is virtually no sign of addition of further oxygen atoms under these conditions. HPLC showed essenti...

example 3

Use of Trimethylmesitylene and Triethylmesitylene Cores

[0312]PK15 was conjugated with tris(bromomethyl)mesitylene under similar conditions to those described earlier with tris(bromomethyl)benzene (Heinis et al., 2009), and purified by HPLC. The conjugate was compared for its ability to inhibit kallikrein according to the procedure set forth in Example 1. Under conditions where PK15-TBMB inhibited kallikrein with an 1050 of 13 nM, preliminary results indicated that the hexamethyl benzene conjugate inhibited kallikrein with an 1050 of 150 nM. PK15 was also conjugated with tris(bromoethyl)mesitylene as above; this led to a further loss of inhibition, with an 1050 of about 400 nM. Thus the change in the nature of the core had a dramatic effect on the affinity of the ligand. In this case, the extra bulk of the three methyl or ethyl groups will likely have altered the packing around the core, and therefore the binding affinity.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for altering the conformational diversity of a first repertoire of polypeptide ligands, comprising a plurality of polypeptides comprising at least two reactive groups separated by a loop sequence covalently linked to a molecular scaffold which forms covalent bonds with said reactive groups, to produce a second repertoire of polypeptide ligands, comprising assembling said second repertoire from the polypeptides and structural scaffold of said first repertoire, incorporating one of the following alterations: (a) altering at least one reactive group; or (b) altering the nature of the molecular scaffold; or (c) altering the bond between at least one reactive group and the molecular scaffold; or (d) any combination of (a), (b) or (c).

Description

[0001]The present application is a continuation of U.S. Ser. No. 13 / 390,252 filed Mar. 14, 2012, which is a filing under 35 USC §371 of PCT / EP2010 / 004948 filed Aug. 12, 2010, which claims priority to GB 0914110.2 filed Aug. 12, 2009.[0002]The present invention relates to peptides whose structure is constrained by binding to a compound which provides a structural backbone, imparting a conformation to the peptide. In particular, the invention relates to modifying the conformational diversity of libraries of such peptides by altering the interaction between the peptides and the structural backbone.[0003]Different research teams have previously tethered polypeptides with cysteine residues to a synthetic molecular structure (Kemp, D. S. and McNamara, P. E., J. Org. Chem, 1985; Timmerman, P. et al., Chem Bio Chem, 2005). Meloen and co-workers had used tris(bromomethyl)benzene and related molecules for rapid and quantitative cyclisation of multiple peptide loops onto synthetic scaffolds fo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N15/10C07K1/00
CPCC07K1/00C12N15/1037C07K1/042C07K1/113C07K2318/00
Inventor WINTER, GREGORY PAULHEINIS, CHRISTIANBERNARD, ELISELOAKES, DAVIDTEUFEL, DANIEL PAUL
Owner BICYCLERD LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com